Novartis AG

( )
NVS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 4.17%139.760.7%$2263.93m
PFEPfizer Inc. 2.65%34.530.9%$1462.96m
MRKMerck & Co., Inc. 5.36%80.340.7%$1347.05m
ABBVAbbVie, Inc. 2.99%75.562.3%$1227.94m
BMYBristol-Myers Squibb Co. 3.98%57.741.0%$1157.01m
LLYEli Lilly & Co. 1.17%141.301.1%$872.78m
NVSNovartis AG 2.58%85.800.2%$305.75m
AZNAstraZeneca Plc 0.77%44.301.2%$301.56m
GSKGlaxoSmithKline Plc 2.10%37.920.2%$258.31m
SNYSanofi 2.88%46.120.2%$176.94m
NVONovo Nordisk A/S 1.40%60.680.1%$171.78m
FTSVForty Seven, Inc. 0.05%95.510.0%$152.45m
BHCBausch Health Cos., Inc. 9.77%14.610.0%$97.57m
RGENRepligen Corp. 2.55%100.717.1%$73.73m
RETAReata Pharmaceuticals, Inc. 7.32%138.293.4%$66.79m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.